These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 6115460)
1. MK-771 enhances the turnover of norepinephrine in brain. Rastogi RB; Singhal RL Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460 [TBL] [Abstract][Full Text] [Related]
2. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone. Agarwal RA; Rastogi RB; Singhal RL Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549 [TBL] [Abstract][Full Text] [Related]
3. MIF-1: effects on norepinephrine, dopamine and serotonin metabolism in certain discrete brain regions. Singhal RL; Rastogi RB Pharmacol Biochem Behav; 1982 Feb; 16(2):229-33. PubMed ID: 6122214 [TBL] [Abstract][Full Text] [Related]
4. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism. Stolk JM; Vantini G; Perry BD; Guchhait RB; U'Prichard DC J Pharmacol Exp Ther; 1984 Sep; 230(3):577-86. PubMed ID: 6147403 [TBL] [Abstract][Full Text] [Related]
6. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action. Itoh Y; Ogasawara T; Mushiroi T; yamazaki A; Ukai Y; Kimura K J Pharmacol Exp Ther; 1994 Nov; 271(2):884-90. PubMed ID: 7965809 [TBL] [Abstract][Full Text] [Related]
7. Norepinephrine release and the activation of tyrosine hydroxylase during nerve stimulation. Lee FL; Weiner N Proc West Pharmacol Soc; 1976; 19():91-6. PubMed ID: 11507 [No Abstract] [Full Text] [Related]
9. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Keller HH; Bartholini G; Pletscher A Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412 [No Abstract] [Full Text] [Related]
10. Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines. Rastogi RB; Singhal RL; Lapierre YD Psychopharmacology (Berl); 1980; 72(1):85-91. PubMed ID: 6110219 [No Abstract] [Full Text] [Related]
11. Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam. Petkov VD; Grahovska T; Petkov VV; Konstantinova E; Stancheva S Acta Physiol Pharmacol Bulg; 1984; 10(4):6-15. PubMed ID: 6535371 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of the TRH analog L-pyro-2-aminoadipyl-L-histidyl-[3H]-L-thiazolidine-4-carboxamide (MK-771) in gut and brain tissue of rats: the implications for its bioavailability. Vickers S; Duncan CA; Arison BH; Ramjit HG; Rosegay A; Nutt RF; Veber DF Drug Metab Dispos; 1983; 11(2):147-51. PubMed ID: 6133720 [TBL] [Abstract][Full Text] [Related]
14. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)]. Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773 [No Abstract] [Full Text] [Related]
15. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Dluzen DE; Story GM; Xu K; Kucera J; Walro JM Exp Neurol; 1999 Dec; 160(2):500-7. PubMed ID: 10619567 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity. Nemeroff CB; Diez JA; Bissette G; Prange AJ; Harrell LE; Lipton MA Pharmacol Biochem Behav; 1977 Apr; 6(4):467-9. PubMed ID: 18744 [TBL] [Abstract][Full Text] [Related]
17. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter. Lemmer B; Schiffer S; Witte K; Gorbey S Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648 [TBL] [Abstract][Full Text] [Related]
18. A short-term diabetes induced changes of catecholamines and p38-MAPK in discrete areas of rat brain. Ramakrishnan R; Kempuraj D; Prabhakaran K; Jayakumar AR; Devi RS; Suthanthirarajan N; Namasivayam A Life Sci; 2005 Aug; 77(15):1825-35. PubMed ID: 16009379 [TBL] [Abstract][Full Text] [Related]
19. The TRH analogue MK-771, increases acetylcholine release in hippocampus but not striatum of the conscious rat. Hutson PH; Semark JE; Middlemiss DN Neurosci Lett; 1990 Aug; 116(1-2):149-55. PubMed ID: 2124336 [TBL] [Abstract][Full Text] [Related]
20. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo. Witten L; Sager T; Thirstrup K; Johansen JL; Larsen DB; Montezinho LP; Mørk A J Neurosci Res; 2009 May; 87(7):1686-94. PubMed ID: 19156859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]